Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis takes aim at Roche's star MS drug
Reuters
Fri, 08/30/19 - 10:08 am
Tags:
Novartis, Roche, multiple sclerosis, Arzerra, ofatumumab, Ocrevus
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
Thu, 08/29/19 - 08:18 pm
Tags:
multiple sclerosis, MS, drug pricing, Biogen, Roche, Sanofi, Novartis, Teva Pharmaceutical, Bayer
Novartis earlier acknowledged Zolgensma data errors to FDA but blamed them on poor reporting
Fierce Pharma
Tue, 08/27/19 - 12:06 pm
Tags:
Novartis, AveXis, Zolgensma, FDA
FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged data manipulation
Endpoints
Fri, 08/23/19 - 10:17 am
Tags:
Novartis, FDA, Zolgensma, AveXis
Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
Endpoints
Thu, 08/22/19 - 11:54 am
Tags:
Novartis, Amgen, Allergan, biosimilars, Roches, Rituxan, ABP 798
FDA on Novartis data manipulation controversy: ‘We happened to be lucky’
Stat
Wed, 08/21/19 - 10:38 am
Tags:
FDA, Novartis
AveXis scientific founder fires back at Novartis CEO Vas Narasimhan, 'categorically denies any wrongdoing'
Endpoints
Mon, 08/19/19 - 11:36 pm
Tags:
Novartis, AveXis, Brian Kaspar, Vas Narasimhan, Zolgensma
Novartis CEO Says FDA Process Could Have Been Handled Better
Bloomberg
Mon, 08/19/19 - 10:33 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, Zolgensma
Mon, 08/19/19 - 10:20 am
Tags:
Regeneron, Novartis, wet-AMD, Eylea, ethics, Vertex Pharmaceuticals, Kalydeco, cystic fibrosis, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, SCLC
Novartis to answer U.S. Senate demand for data manipulation details
Yahoo/Reuters
Mon, 08/19/19 - 09:55 am
Tags:
Novartis, Senate, Zolgensma
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Tags:
Regeneron, Novartis, wet-AMD, Eylea, ethics, Vertex Pharmaceuticals, Kalydeco, cystic fibrosis, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, SCLC
Warning signs were always there for Novartis’s Avexis deal
EP Vantage
Fri, 08/16/19 - 10:01 am
Tags:
Novartis, AveXis
AveXis scientific founder is out as Novartis names a new CSO in wake of an ethics scandal
Endpoints
Wed, 08/14/19 - 11:15 am
Tags:
Novartis, AveXis, Zolgensma, FDA
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Tags:
Novartis, Sandoz, biosimilars, Amgen, Enbrel, patents, Erelzi
Novartis names Bulto as new head of U.S. drugs business
Yahoo/Reuters
Wed, 08/14/19 - 10:15 am
Tags:
Novartis, Victor Bulto
Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation
Fierce Pharma
Tue, 08/13/19 - 11:20 pm
Tags:
Novartis, FDA, Zolgensma
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
Tags:
drug approvals, FDA, AbbVie, JNJ, Novartis, Pfizer, Skyrizi, psoriasis, Vyndaqel, Zolgensma, SMA, Mayzent, multiple sclerosis, Balversa, metastatic bladder cancer
Questions pile up for Novartis as senators call on FDA to take action
Endpoints
Tue, 08/13/19 - 11:41 am
Tags:
Novartis, FDA, Senate, Zolgensma
Novartis sells phase 3 rare disease drug to Pharming
Fierce Biotech
Tue, 08/13/19 - 10:06 am
Tags:
Novartis, Pharming, leniolisib
Questions Pile up for Novartis as Senators Call on FDA to Take Action
RAPS.org
Mon, 08/12/19 - 05:28 pm
Tags:
FDA, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.